Clinical Trial Update: Study of NTBC for Tyrosinemia I [NA]

View source ↗

Summary

Completed clinical trial evaluating NTBC (nitisinone) for Tyrosinemia type I.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tyrosinemia Type

Drugs mentioned

• Nitisinone (Nitisinone)

Snippet

Sponsor: University of Washington | Conditions: Tyrosinemia I | NA | Status: COMPLETED